
    
      An open label, balanced, randomized, two-treatment, two-period, two-sequence,single dose,
      crossover, oral bioequivalence study of Eszopiclone tablets 3 mg of Dr. Reddy's Laboratories
      limited, and 'LUNESTA' tablets 3 mg Mfg for Sepracor Inc. USA in healthy adult human subjects
      under fasting conditions.
    
  